Fragmento

Gemcitabina en el cáncer de pulmón de células no pequeñas: ¿solamente otro fármaco más? Lung cancer is the leading cause of cancer death in Mexico and most countries. This highly lathal malignancy remains as a great challenge to oncologists due to its aggressive tumor biology and poor sensitivity to radiation and chemotherapy. In addition, no screening strategies have shown benefit in terms of reducing its mortality...

Palabras clave: .

2002-12-24   |   1,030 visitas   |   Evalua este artículo 0 valoraciones

Vol. 46 Núm.3. Julio-Septiembre 2000 Pags. 150-151. Rev Inst Nal Cancerol Méx 2000; 46(3)